# FDA 483 - Novartis Gene Therapies, Inc. - August 02, 2019

Source: https://www.globalkeysolutions.net/records/483/novartis-gene-therapies-inc/91f9bee6-7ad5-4836-8f07-46468e2a2510

> FDA 483 for Novartis Gene Therapies, Inc. on August 02, 2019. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Novartis Gene Therapies, Inc.
- Inspection Date: 2019-08-02
- Office Name: Los Angeles District Office

## Related Documents

- [EIR - 2019-02-15](https://www.globalkeysolutions.net/records/eir/novartis-gene-therapies-inc/f5f81226-4da7-4cdc-91da-5e61e1786be0)
- [OTHER_CORRESPONDENCE - 2019-08-02](https://www.globalkeysolutions.net/records/other_correspondence/novartis-gene-therapies-inc/e848efbe-98af-4b81-a414-7d8ed0d1aa0e)

## Related Officers

- [Scott T. Ballard](https://www.globalkeysolutions.net/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [CSO](https://www.globalkeysolutions.net/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)

Company: https://www.globalkeysolutions.net/companies/novartis-gene-therapies-inc/04406f28-2c1b-4c68-ab75-a9862bfc9169

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b